Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors (clinicaltrials.gov) - Oct 14, 2026 - P2 | N=59 | Not yet recruiting | Sponsor: Joal Beane | Initiation date: Aug 2026 ➔ Feb 2027
Trial initiation date • Gastrointestinal Cancer • Gastrointestinal Stromal Tumor • Oncology • Sarcoma
|